CRH plc, together with its subsidiaries, provides building materials solutions in Ireland, the United States, the United Kingdom, rest of Europe, and internatio…
$93.16-0.40%
报价 2026-11-13
市值
$61.97B
EV
$80.51B
PE (TTM)
17.0x
预期 PE (FY2027)
15.3x
52 周区间距高点 -29.1%
$79.20$131.38
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
电话会信号
辅助标签Q3 20262026-10-29
扩产AI 词频高下调/撤回指引供不应求
指引 下调
信心 4
分析师 3
“We expect a positive price cost spread and a return to margin expansion in 2027.”
原文引用（3）
- 扩产：invested $1.2 billion in growth CapEx... to expand capacity in high-growth markets
- 下调/撤回指引：we are updating our financial guidance and now expect full-year Adjusted EBITDA to be between $7.8 billion and $8.0 billion
- 供不应求：strong order backlogs with lead times out to 12 months across the engineered structure business
蓝色标签在暴涨研究中略有区分度；悬停查看口径。
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Construction Materials| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CRHCRH plc | $61.97B | -0.4% | +8.1% | 38.8% | 17.0x | 8.9x | 25.2x | |
| VMCVulcan Materials Company | $35.76B | -0.6% | +0.5% | 30.5% | 32.2x | 15.6x | 45.8x | |
| MLMMartin Marietta Materials, Inc. | $30.85B | -0.7% | +17.4% | 25.4% | 12.7x | 17.8x | 38.5x | GARP |
| AMRZAmrize Ltd | $22.36B | +0.1% | +4.2% | 28.7% | – | – | – | |
| JHXJames Hardie Industries plc | $16.17B | +0.9% | +6.5% | 37.2% | 117.9x | 20.0x | 48.9x | |
| CXCEMEX, S.A.B. de C.V. | $15.31B | +0.8% | – | 32.4% | 11.4x | 8.3x | – | |
| EXPEagle Materials Inc. | $5.5B | -0.8% | +2.2% | 28.3% | 13.7x | 9.3x | 35.3x | |
| KNFKnife River Corporation | $3.2B | -0.7% | +9.0% | 22.5% | 24.7x | 9.6x | – | |
| USLMUnited States Lime & Minerals, Inc. | $3.19B | -2.7% | +11.5% | 48.9% | 25.6x | 16.5x | 32.3x | |
| 同行中位数 | – | – | +6.5% | 29.6% | 24.7x | 15.6x | 38.5x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.4B | $10.78B | $7.37B | $9.42B | $11.07B | $10.21B | $6.76B | $8.87B |
| Gross Margin | 38.8% | 39.8% | 27.7% | 35.6% | 38.9% | 39.4% | 27.2% | 35.6% |
| Operating Margin | 16.6% | 19.3% | -0.5% | 14.9% | 18.8% | 19% | 0.3% | 12.4% |
| Net Income | $1.25B | $1.49B | $-176M | $1.03B | $1.5B | $1.32B | $-94M | $703M |
| Diluted EPS | 1.86 | 2.21 | -0.27 | 1.52 | 2.21 | 1.94 | -0.15 | 1.02 |
| Operating Cash Flow | $1.76B | $1.13B | $-616M | $2.92B | $1.99B | $1.38B | $-659M | $2.73B |
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。